Fingolimod: a novel immunosuppressant for multiple sclerosis.
about
Atacicept: targeting B cells in multiple sclerosisPharmacological tools for lysophospholipid GPCRs: development of agonists and antagonists for LPA and S1P receptors.Prevention, but not cure, of autoimmune diabetes in a NOD.scid transfer model by FTY720 despite effective modulation of blood T cells.A review of safety-related pregnancy data surrounding the oral disease-modifying drugs for multiple sclerosis.Essential requirement for PP2A inhibition by the oncogenic receptor c-KIT suggests PP2A reactivation as a strategy to treat c-KIT+ cancersAxon growth inhibition by RhoA/ROCK in the central nervous system.Disease modifying agents for multiple sclerosis.Ceramide synthesis is modulated by the sphingosine analog FTY720 via a mixture of uncompetitive and noncompetitive inhibition in an Acyl-CoA chain length-dependent manner.Pulmonary endothelial cell barrier enhancement by novel FTY720 analogs: methoxy-FTY720, fluoro-FTY720, and β-glucuronide-FTY720.Synthetic analogs of FTY720 [2-amino-2-(2-[4-octylphenyl]ethyl)-1,3-propanediol] differentially regulate pulmonary vascular permeability in vivo and in vitro.Early safety and efficacy of fingolimod treatment in Denmark.A Stability-Indicating HPLC Method for the Determination of Fingolimod in Pharmaceutical Dosage Forms.FTY720 stimulated ROS generation and the Sty1/Atf1 signaling pathway in the fission yeast Schizosaccharomyces pombe.FTY-720 induces apoptosis in neuroblastoma via multiple signaling pathways.
P2860
Q24628925-98911DBC-3A87-4F0A-848A-6390E3FFC282Q30410634-4C53E8C8-AC7B-4540-BF9E-8B0007634430Q30428016-7697C21D-CB72-4C92-ADC2-ACEFE89056E4Q30716854-E5985049-C15C-4914-ADF1-929C86CCF7C5Q34104555-E0E128BF-3A90-4223-992E-2180BF19F879Q34384966-DCECE8D2-F627-489D-890B-8A8D979EF895Q34508451-FA6C8D3A-D12D-403E-A626-AEE8D536BDFFQ34974825-D2FF3555-2529-455B-AAD5-043A8EC171FCQ36306831-939F54F5-A5B1-4CC6-B18A-54367CA702EEQ37397209-32B4B247-F83A-4393-ACA8-37E527D1554EQ39137395-F650B9FA-02E9-4EDB-B4A6-BD978EDF055EQ43067167-1A137349-042C-4CB6-9976-F83AFF4DDEC8Q46934699-09E06893-5D44-4D1A-8C93-A8375CD7D706Q47107017-E830C045-A133-4160-B24B-5FDC5BC0A28C
P2860
Fingolimod: a novel immunosuppressant for multiple sclerosis.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Fingolimod: a novel immunosuppressant for multiple sclerosis.
@en
type
label
Fingolimod: a novel immunosuppressant for multiple sclerosis.
@en
prefLabel
Fingolimod: a novel immunosuppressant for multiple sclerosis.
@en
P2093
P2860
P356
P1476
Fingolimod: a novel immunosuppressant for multiple sclerosis.
@en
P2093
Brandon A Brown
Lisa M McDevitt
Pranish P Kantesaria
P2860
P304
P356
10.1345/APH.1G424
P407
P577
2007-09-04T00:00:00Z